Plasma Medical Devices

[INQ. NO. 2610E05] FEAGLE Co., Ltd., a company specializing in plasma medical devices, has been focusing its R&D efforts on the field of plasma medicine, an area gaining attention as next-generation medical technology.
Over the past 12 years of plasma technology research, FEAGLE has expanded its product lineup to include everything from medical devices for hospitals and clinics to equipment for aesthetic clinics and beauty devices for home care.
Its core technology is the proprietary Nozone Cold Plasma (NCP). According to FEAGLE, NCP is designed to maintain the characteristics of cold plasma while minimizing ozone generation during the plasma-production process — reducing levels to less than one-tenth of the standards set by the FDA and the Ministry of Food and Drug Safety.

FEAGLE is expanding the scope of its technology beyond professional equipment to include homecare products for consumers. Its flagship product, PLUNA, is a personal plasma beauty device based on NCP technology; it brings plasma technology — previously reserved for professional facilities — into the realm of everyday skincare.
PLUNA features a portable, handheld design and is engineered to enable plasma-based homecare, while minimizing direct physical irritation to the skin. The company’s strategy is to target both professional and consumer markets by applying the same core plasma technology to products for clinics and home-use alike.

Alongside its technological development, FEAGLE is accelerating its expansion into overseas markets. It is currently selling products or conducting local medical device certification and pre-marketing activities in regions including Hong Kong, the USA, Mexico, Indonesia, Malaysia, Vietnam, and Russia. In particular, viewing the United States as a key market, FEAGLE has spent approximately a year conducting local testing and market validation, and is now moving to significantly expand sales based on these results. FEAGLE is also pursuing medical-device certification in countries such as Mexico, Russia, and Thailand, with plans to expand local distribution and marketing once certification is secured.
In the long term, FEAGLE plans to develop its NCP technology into a platform capable of overcoming the limitations — such as physical irritation and invasiveness — associated with conventional medical and beauty devices. With the demand for non-invasive treatments and care steadily rising, the company aims to expand its plasma technology into a diverse range of medical and aesthetic products, thereby tapping into new application markets.

korean-electronics.com | Blog Magazine of korean electronics, brands and Goods